King's Mill Hospital is an acute general district hospital serving the population of north Nottinghamshire and parts of Derbyshire and Lincolnshire. It is managed by the Sherwood Forest Hospitals NHS Foundation Trust.

There are 600 beds in King's Mill Hospital.

During the past decade, King's Mill Hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 7 clinical trials were completed, i.e. on average, 28% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King's Mill Hospital" #1 sponsor was "University College, London" with 6 trials, followed by "University of Nottingham" with 5 trials sponsored, "Celgene" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King's Mill Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator and "Action Medical Research" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "King's Mill Hospital" are "Prostate Cancer" (5 trials), "Atrial Fibrillation" (3 trials), "Breast Cancer" (3 trials), "Fallopian Tube Cancer" (3 trials) and "Lung Cancer" (3 trials). Many other conditions were trialed in "King's Mill Hospital" in a lesser frequency.

Most popular intervention types in "King's Mill Hospital" are "Drug" (29 trials), "Other" (13 trials), "Device" (4 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Docetaxel" (2 trials), "Edoxaban" (2 trials), "Luspatercept" (2 trials) and "Prednisolone" (2 trials). Other intervention names were less common.

The vast majority of trials in "King's Mill Hospital" are 40 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "King's Mill Hospital". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in King's Mill Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in King's Mill Hospital, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".